Global Biopharmaceutical Excipients Market Size & Outlook
Global biopharmaceutical excipients market, 2021-2033 (US$M)
Related Markets
Global biopharmaceutical excipients market highlights
- The global biopharmaceutical excipients market generated a revenue of USD 3,179.8 million in 2025 and is expected to reach USD 4,966.1 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 5.8% by 2033.
- In terms of segment, solubilizes & surfactants/emulsifiers accounted for a revenue of USD 1,241.2 million in 2025.
- Specialty Excipients is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 3,179.8 million |
| Market revenue in 2033 | USD 4,966.1 million |
| Growth rate | 5.8% (CAGR from 2026 to 2033) |
| Largest segment | Solubilizes & surfactants/emulsifiers |
| Fastest growing segment | Specialty Excipients |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Specialty Excipients, Solubilizes & Surfactants/Emulsifiers, Polyols, Carbohydrates |
Other key industry trends
- In terms of revenue, the North America accounted for 34.0% of the global biopharmaceutical excipients market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, India is the fastest growing regional market and is projected to reach USD 176.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Excipients Market Scope
Biopharmaceutical Excipients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| J. Rettenmaier & Söhne | View profile | 101-250 | Holzmühle, Sachsen, Germany, Europe | https://www.jrs.eu |
| DFE Pharma | View profile | 251-500 | Goch, Nordrhein-Westfalen, Germany, Europe | https://www.dfepharma.com/ |
| Sigachi | View profile | 501-1000 | Hyderabad, Andhra Pradesh, India, Asia | https://sigachi.com |
| Spectrum Chemical Manufacturingrp | View profile | 101-250 | New Brunswick, New Jersey, United States, North America | https://www.spectrumchemical.com |
| Colorcon | View profile | 1001-5000 | Harleysville, Pennsylvania, United States, North America | https://www.colorcon.com |
| IMCD NV | View profile | 4948 | Wilhelminaplein 32, Rotterdam, Netherlands, 3072 DE | https://www.imcdgroup.com |
| Roquette America | View profile | 5001-10000 | Gurnee, Illinois, United States, North America | https://www.roquette.com/ |
| Clariant AG | View profile | 10481 | Rothausstrasse 61, Muttenz, Switzerland, 4132 | http://www.clariant.com |
| Associated British Foods PLC | View profile | 133000 | 10 Grosvenor Street, Weston Centre, London, United Kingdom, W1K 4QY | https://www.abf.co.uk |
| Evonik Industries AG | View profile | 33409 | Rellinghauser Strasse 1-11, Essen, NW, Germany, 45128 | https://www.evonik.com |
| Basf SE | View profile | 111855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | https://www.basf.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Global biopharmaceutical excipients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical excipients market will help companies and investors design strategic landscapes.
Solubilizes & surfactants/emulsifiers was the largest segment with a revenue share of 39.03% in 2025. Horizon Databook has segmented the Global biopharmaceutical excipients market based on specialty excipients, solubilizes & surfactants/emulsifiers, polyols, carbohydrates covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Biopharmaceutical Excipients Product Outlook (Revenue, USD Million, 2021-2033)
- Specialty Excipients
- Solubilizes & Surfactants/Emulsifiers
- Triglycerides
- Esters
- Others
- Polyols
- Mannitol
- Sorbitol
- Others
- Carbohydrates
- Sucrose
- Dextrose
- Starch
- Others
- Global Biopharmaceutical Excipients Material Outlook (Revenue, USD Million, 2021-2033)
- Sugars & Polyols
- Polymers
- Amino Acids
- Inorganic Salts & Buffers
- Specialty Co-Processed Excipients / Novel Excipients
- Global Biopharmaceutical Excipients Dosage Form Outlook (Revenue, USD Million, 2021-2033)
- Parenteral (Liquid injectables)
- Lyophilized (Freeze-dried)
- Others
- Global Biopharmaceutical Excipients Therapeutic Modality Outlook (Revenue, USD Million, 2021-2033)
- Monoclonal Antibodies
- Recombinant Proteins & Enzymes
- Vaccines
- Cell & Gene Therapy Formulations
- Peptides & Oligonucleotides
Reasons to subscribe to Global biopharmaceutical excipients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biopharmaceutical excipients market databook
-
Our clientele includes a mix of biopharmaceutical excipients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biopharmaceutical excipients market , including forecasts for subscribers. This global databook contains high-level insights into Global biopharmaceutical excipients market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global biopharmaceutical excipients market size, by regions, 2021-2033 (US$M)
Top 10 countries: Biopharmaceutical excipients market size, 2023 (US$M)
Global biopharmaceutical excipients market share, by product, 2023 & 2030 (%, US$M)
Biopharmaceutical excipients market: Opportunity assessment by country
Global biopharmaceutical excipients market, by region, 2025 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
